| CAS: | 2485-71-4 | ||
| 分子式: | C15H30O2 | ||
| 分子量: | 242.40 | ||
| 英文名称: |
|
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |||||||||||||||||||||||||||||||||||
| M912341 | MACKLIN | 13-methyl Myristic Acid | 98% | 886元/10mg; 1770元/25mg; 5111元/100mg; | 咨询 | ||||||||||||||||||||||||||||||||||
储存:-20°C,密闭,干燥 | |||||||||||||||||||||||||||||||||||||||
| 857511P | Avanti | Iso 15:0 Fatty Acid | Avanti Polar Lipids (857511P), powder | 1488.85元/10 MG; 2978.26元/25 MG; | 咨询 | ||||||||||||||||||||||||||||||||||
产品说明 一般描述 Iso 15:0 Fatty Acid, also known as 13-Methyltetradecanoic acid, belongs to the family of branched chain fatty acids (BCFA). It is obtained from soy fermentation products. 生化/生理作用 Iso 15:0 fatty acid possesses anti-cancer activity in various human cancer cells. 包装 5 mL Amber Glass Screw Cap Vial (857511P-10MG and 857511P-25MG) 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||
| HY-131503 | MCE | 13-Methyltetradecanoic acid,2485-71-4,13-甲基十四烷酸_MCE(MedChemExpress) | 990元/10 mM * 1 mL in Ethanol; 900元/5 mg; 1530元/10 mg; 2700元/25 mg; 4500元/50 mg; | 咨询 | |||||||||||||||||||||||||||||||||||
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。 13-Methyltetradecanoic acidMCE 国际站:13-Methyltetradecanoic acid 品牌:MedChemExpress (MCE) 货号:HY-131503 CAS 号:2485-71-4 生物活性: 13-甲基十四烷酸(13-MTD)是一种具有强效抗癌作用的饱和支链脂肪酸。13-甲基十四烷酸可诱导多种人类癌细胞凋亡[1][2]。 体外研究(In Vitro):13-Methyltetradecanoic acid (13-MTD; 0-140 μg/mL; 12-24 hours) inhibits cell viability and proliferation in human bladder cancer cells by inducing apoptosis[1]. 13-Methyltetradecanoic acid (13-MTD; 70 μg/mL; 2-48 hours) treatments results in significant accumulation of cells with sub-G1 DNA content in a time-dependent manner, with the proportion of sub-G1 phase DNA content ranging from 9.25% to 85.3% over 2-48 hours[1]. 13-Methyltetradecanoic acid (13-MTD; 70 μg/mL; 2-24 hours) down-regulates Bcl-2 and up-regulates Bax. This promotes mitochondrial dysfunction, leading to the release of cytochrome c from the mitochondria to the cytoplasm, as well as the proteolytic activation of caspases. 13-Methyltetradecanoic acid down-regulates AKT phosphorylation and activates phosphorylation of p38 and c-Jun N-terminal kinase (JNK)[1]. MCE尚未独立确认这些方法的准确性。 仅供参考。 体内研究(In Vivo):13-Methyltetradecanoic acid (13-MTD; 70 mg/kg/day; oral gavage; daily; for 30 days) significantly suppresses tumor growth in a xenograft model[2]. MCE尚未独立确认这些方法的准确性。 仅供参考。 分子量:242.40 Formula:C15H30O2 性状:固体 颜色:White to off-white 中文名称:13-甲基十四烷酸 运输条件:美国大陆地区的室温;其他地区可能有所不同。 储存方式:粉末 -20°C 3年 提供质量检测报告:Data Sheet、SDS、COA、HNMR、RP-HPLC、产品使用指南 产品活性:13-Methyltetradecanoic acid (13-MTD),一种具有强效抗癌作用的饱和支链脂肪酸。13-Methyltetradecanoic acid 在多种类型的人类癌细胞中诱导细胞凋亡 (apoptosis)。 相关产品:MG-132 | Stearic acid (Standard) | Galunisertib | Stearic acid | Galunisertib (Standard) | Palmitoleic acid | MG-132 | Palmitoleic acid (Standard) | Eragidomide | Luc Yellow CH dilithium | Colivelin | Gondoic acid 热门产品线:抑制剂 | 稳定性同位素标记物 | 脂质 | 糖类 Trending products:Inhibitors | Isotope-Labeled Compounds | Lipids | Saccharides MCE 抑制剂: MedChemExpress 信号通路产品覆盖细胞凋亡、自噬、细胞周期与 DNA 损伤、表观遗传、GPCR/G 蛋白、免疫与炎症、JAK/STAT、MAPK/ERK、膜转运体与离子通道、代谢酶与蛋白酶、神经信号、NF-κB、PI3K/Akt/mTOR、PROTAC、蛋白酪氨酸激酶/受体酪氨酸激酶、干细胞/Wnt、TGF-β/Smad 及维生素 D/核受体等研究方向,为肿瘤、感染、炎症与免疫、神经系统疾病、代谢性疾病、心血管疾病和内分泌研究提供多维度的产品选择,助力客户发表文献超 80,000 篇。 相关产品可根据具体情况提供化学结构、作用靶点、生物活性、纯度、溶解度、体内外研究信息、参考文献及质量分析报告 (COA)等资料。 客户发表文献: 参考文献: 品牌介绍:
| |||||||||||||||||||||||||||||||||||||||